12-753114-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018979.4(WNK1):​c.-452G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0457 in 153,078 control chromosomes in the GnomAD database, including 211 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 210 hom., cov: 31)
Exomes 𝑓: 0.048 ( 1 hom. )

Consequence

WNK1
NM_018979.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.424

Publications

1 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 12-753114-G-A is Benign according to our data. Variant chr12-753114-G-A is described in ClinVar as [Benign]. Clinvar id is 310519.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0868 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.-452G>A 5_prime_UTR_variant Exon 1 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.-452G>A 5_prime_UTR_variant Exon 1 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.-452G>A 5_prime_UTR_variant Exon 1 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.-452G>A 5_prime_UTR_variant Exon 1 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.0457
AC:
6927
AN:
151530
Hom.:
210
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0103
Gnomad AMI
AF:
0.0135
Gnomad AMR
AF:
0.0552
Gnomad ASJ
AF:
0.0651
Gnomad EAS
AF:
0.0936
Gnomad SAS
AF:
0.0263
Gnomad FIN
AF:
0.0775
Gnomad MID
AF:
0.0892
Gnomad NFE
AF:
0.0570
Gnomad OTH
AF:
0.0552
GnomAD4 exome
AF:
0.0479
AC:
69
AN:
1440
Hom.:
1
Cov.:
0
AF XY:
0.0395
AC XY:
31
AN XY:
784
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
50
American (AMR)
AF:
0.0263
AC:
1
AN:
38
Ashkenazi Jewish (ASJ)
AF:
0.0690
AC:
4
AN:
58
East Asian (EAS)
AF:
0.0714
AC:
2
AN:
28
South Asian (SAS)
AF:
0.0238
AC:
2
AN:
84
European-Finnish (FIN)
AF:
0.136
AC:
3
AN:
22
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
6
European-Non Finnish (NFE)
AF:
0.0518
AC:
56
AN:
1082
Other (OTH)
AF:
0.0139
AC:
1
AN:
72
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0456
AC:
6920
AN:
151638
Hom.:
210
Cov.:
31
AF XY:
0.0459
AC XY:
3404
AN XY:
74114
show subpopulations
African (AFR)
AF:
0.0103
AC:
426
AN:
41486
American (AMR)
AF:
0.0552
AC:
841
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
0.0651
AC:
226
AN:
3472
East Asian (EAS)
AF:
0.0937
AC:
482
AN:
5146
South Asian (SAS)
AF:
0.0259
AC:
125
AN:
4826
European-Finnish (FIN)
AF:
0.0775
AC:
811
AN:
10468
Middle Eastern (MID)
AF:
0.0788
AC:
23
AN:
292
European-Non Finnish (NFE)
AF:
0.0570
AC:
3859
AN:
67712
Other (OTH)
AF:
0.0547
AC:
115
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
352
703
1055
1406
1758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0208
Hom.:
7
Bravo
AF:
0.0444
Asia WGS
AF:
0.0330
AC:
112
AN:
3394

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pseudohypoaldosteronism type 2C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
12
DANN
Benign
0.95
PhyloP100
-0.42
PromoterAI
0.046
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118007973; hg19: chr12-862280; API